Literature DB >> 23539499

Aflatoxins, hepatocellular carcinoma and public health.

Arvin Magnussen, Mansour A Parsi.   

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths worldwide, primarily affecting populations in the developing countries. Aflatoxin, a food contaminant produced by the fungi Aspergillus flavus and Aspergillus parasiticus, is a known human carcinogen that has been shown to be a causative agent in the pathogenesis of HCC. Aflatoxin can affect a wide range of food commodities including corns, oilseeds, spices, and tree nuts as well as milk, meat, and dried fruit. Many factors affect the growth of Aspergillus fungi and the level of aflatoxin contamination in food. Drought stress is one of the factors that increase susceptibility of plants to Aspergillus and thus aflatoxin contamination. A recent drought is thought to be responsible for finding of trace amounts of aflatoxin in some of the corn harvested in the United States. Although it's too soon to know whether aflatoxin will be a significant problem, since United States is the world's largest corn producer and exporter, this has raised alarm bells. Strict regulations and testing of finished foods and feeds in the United States should prevent a major health scare, and prevent human exposure to deleterious levels of aflatoxin. Unfortunately, such regulations and testing are not in place in many countries. The purpose of this editorial is to summarize the current knowledge on association of aflatoxin and HCC, encourage future research and draw attention to this global public health issue.

Entities:  

Keywords:  Aflatoxins; Environmental health; Food safety; Hepatocellular carcinoma; Public health

Mesh:

Substances:

Year:  2013        PMID: 23539499      PMCID: PMC3602466          DOI: 10.3748/wjg.v19.i10.1508

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 2.  Toxigenic fungi and mycotoxins.

Authors:  J I Pitt
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

3.  Estimates of the worldwide incidence of 25 major cancers in 1990.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

Review 4.  Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease.

Authors:  P Khlangwiset; F Wu
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-07

Review 5.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

6.  Aflatoxin, kwashiorkor, and morbidity.

Authors:  M Adhikari; P Berjak
Journal:  Nat Toxins       Date:  1994

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

9.  Mycotoxins and human disease: a largely ignored global health issue.

Authors:  Christopher P Wild; Yun Yun Gong
Journal:  Carcinogenesis       Date:  2009-10-29       Impact factor: 4.944

Review 10.  How are children different from adults?

Authors:  C F Bearer
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

View more
  31 in total

1.  The effects of aflatoxin exposure on Hepatitis B-vaccine induced immunity in Kenyan children.

Authors:  D Githang'a; R N Wangia; M W Mureithi; S O Wandiga; C Mutegi; B Ogutu; A Agweyu; J-S Wang; O Anzala
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2019-05-16

Review 2.  Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma.

Authors:  Mahmoud Khattab; Magdy Fouad; Elham Ahmed
Journal:  World J Hepatol       Date:  2015-10-18

Review 3.  Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

Authors:  Aastha Jindal; Anusha Thadi; Kunwar Shailubhai
Journal:  J Clin Exp Hepatol       Date:  2019-01-25

4.  Integrated proteome and HPLC analysis revealed quercetin-mediated inhibition of aflatoxin B1 biosynthesis in Aspergillus flavus.

Authors:  Shraddha Tiwari; Jata Shankar
Journal:  3 Biotech       Date:  2018-01-03       Impact factor: 2.406

Review 5.  Roles for the mycobiome in liver disease.

Authors:  Suling Zeng; Bernd Schnabl
Journal:  Liver Int       Date:  2022-01-17       Impact factor: 5.828

6.  Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Yi-Chuan Yu; Hung N Luu; Renwei Wang; Claire E Thomas; Nancy W Glynn; Ada O Youk; Jaideep Behari; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-14       Impact factor: 4.090

7.  Projections of primary liver cancer to 2030 in 30 countries worldwide.

Authors:  Patricia C Valery; Mathieu Laversanne; Paul J Clark; Jessica L Petrick; Katherine A McGlynn; Freddie Bray
Journal:  Hepatology       Date:  2017-12-23       Impact factor: 17.425

8.  Effects of packaging and pre-storage treatments on aflatoxin production in peanut storage under controlled conditions.

Authors:  Clara Darko; Parameswaran Kumar Mallikarjunan; Hande Kaya-Celiker; Emmanuel Anokye Frimpong; Komla Dizisi
Journal:  J Food Sci Technol       Date:  2018-02-03       Impact factor: 2.701

Review 9.  Dairy consumption and hepatocellular carcinoma risk.

Authors:  Bodo C Melnik
Journal:  Ann Transl Med       Date:  2021-04

10.  Non-linear relationships between aflatoxin B₁ levels and the biological response of monkey kidney vero cells.

Authors:  Reuven Rasooly; Bradley Hernlem; Xiaohua He; Mendel Friedman
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.